GPAT Net Income From Continuing Ops from 2010 to 2026
| GPAT Stock | 10.73 0.01 0.09% |
Net Income From Continuing Ops | First Reported 2010-12-31 | Previous Quarter 10 M | Current Value 10.5 M | Quarterly Volatility 3.8 M |
Check GP Act financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GP Act's main balance sheet or income statement drivers, such as Other Operating Expenses of 682.2 K, Ebitda of 10.5 M or Total Operating Expenses of 682.2 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.41. GPAT financial statements analysis is a perfect complement when working with GP Act Valuation or Volatility modules.
GPAT | Net Income From Continuing Ops | Build AI portfolio with GPAT Stock |
The evolution of Net Income From Continuing Ops for GP Act III Acquisition provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how GP Act compares to historical norms and industry peers.
Latest GP Act's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of GP Act III Acquisition over the last few years. It is GP Act's Net Income From Continuing Ops historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in GP Act's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
GPAT Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | 1,688,241 | |
| Geometric Mean | 81,212 | |
| Coefficient Of Variation | 227.42 | |
| Mean Deviation | 2,829,458 | |
| Median | (30,844) | |
| Standard Deviation | 3,839,346 | |
| Sample Variance | 14.7T | |
| Range | 10.5M | |
| R-Value | 0.67 | |
| Mean Square Error | 8.8T | |
| R-Squared | 0.44 | |
| Significance | 0 | |
| Slope | 505,728 | |
| Total Sum of Squares | 235.8T |
GPAT Net Income From Continuing Ops History
About GP Act Financial Statements
GP Act shareholders use historical fundamental indicators, such as Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although GP Act investors may analyze each financial statement separately, they are all interrelated. The changes in GP Act's assets and liabilities, for example, are also reflected in the revenues and expenses on on GP Act's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 10 M | 10.5 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for GPAT Stock Analysis
When running GP Act's price analysis, check to measure GP Act's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GP Act is operating at the current time. Most of GP Act's value examination focuses on studying past and present price action to predict the probability of GP Act's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GP Act's price. Additionally, you may evaluate how the addition of GP Act to your portfolios can decrease your overall portfolio volatility.